These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36949537)

  • 1. Clusters of co-abundant proteins in the brain cortex associated with fronto-temporal lobar degeneration.
    Bridel C; van Gils JHM; Miedema SSM; Hoozemans JJM; Pijnenburg YAL; Smit AB; Rozemuller AJM; Abeln S; Teunissen CE
    Alzheimers Res Ther; 2023 Mar; 15(1):59. PubMed ID: 36949537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein L1 is increased in frontotemporal lobar degeneration post-mortem brain but not in ante-mortem cerebrospinal fluid.
    Hok-A-Hin YS; Dijkstra AA; Rábano A; Hoozemans JJ; Castillo L; Seelaar H; van Swieten JC; Pijnenburg YAL; Teunissen CE; Del Campo M
    Neurobiol Dis; 2022 Oct; 172():105813. PubMed ID: 35820647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma proteome profiling identifies changes associated to AD but not to FTD.
    Mofrad RB; Del Campo M; Peeters CFW; Meeter LHH; Seelaar H; Koel-Simmelink M; Ramakers IHGB; Middelkoop HAM; De Deyn PP; Claassen JAHR; van Swieten JC; Bridel C; Hoozemans JJM; Scheltens P; van der Flier WM; Pijnenburg YAL; Teunissen CE
    Acta Neuropathol Commun; 2022 Oct; 10(1):148. PubMed ID: 36273219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain DNA methylomic analysis of frontotemporal lobar degeneration reveals OTUD4 in shared dysregulated signatures across pathological subtypes.
    Fodder K; Murthy M; Rizzu P; Toomey CE; Hasan R; Humphrey J; Raj T; Lunnon K; Mill J; Heutink P; Lashley T; Bettencourt C
    Acta Neuropathol; 2023 Jul; 146(1):77-95. PubMed ID: 37149835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuronal cytoplasmic inclusions in tau, TDP-43, and FUS molecular subtypes of frontotemporal lobar degeneration share similar spatial patterns.
    A Armstrong R
    Folia Neuropathol; 2017; 55(3):185-192. PubMed ID: 28984110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinguishing Frontotemporal Lobar Degeneration Tau From TDP-43 Using Plasma Biomarkers.
    Cousins KAQ; Shaw LM; Chen-Plotkin A; Wolk DA; Van Deerlin VM; Lee EB; McMillan CT; Grossman M; Irwin DJ
    JAMA Neurol; 2022 Nov; 79(11):1155-1164. PubMed ID: 36215050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced Tau protein expression is associated with frontotemporal degeneration with progranulin mutation.
    Papegaey A; Eddarkaoui S; Deramecourt V; Fernandez-Gomez FJ; Pantano P; Obriot H; Machala C; Anquetil V; Camuzat A; Brice A; Maurage CA; Le Ber I; Duyckaerts C; Buée L; Sergeant N; Buée-Scherrer V
    Acta Neuropathol Commun; 2016 Jul; 4(1):74. PubMed ID: 27435172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration.
    Cairns NJ; Bigio EH; Mackenzie IR; Neumann M; Lee VM; Hatanpaa KJ; White CL; Schneider JA; Grinberg LT; Halliday G; Duyckaerts C; Lowe JS; Holm IE; Tolnay M; Okamoto K; Yokoo H; Murayama S; Woulfe J; Munoz DG; Dickson DW; Ince PG; Trojanowski JQ; Mann DM;
    Acta Neuropathol; 2007 Jul; 114(1):5-22. PubMed ID: 17579875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antemortem volume loss mirrors TDP-43 staging in older adults with non-frontotemporal lobar degeneration.
    Bejanin A; Murray ME; Martin P; Botha H; Tosakulwong N; Schwarz CG; Senjem ML; Chételat G; Kantarci K; Jack CR; Boeve BF; Knopman DS; Petersen RC; Giannini C; Parisi JE; Dickson DW; Whitwell JL; Josephs KA
    Brain; 2019 Nov; 142(11):3621-3635. PubMed ID: 31562527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caudate atrophy on MRI is a characteristic feature of FTLD-FUS.
    Josephs KA; Whitwell JL; Parisi JE; Petersen RC; Boeve BF; Jack CR; Dickson DW
    Eur J Neurol; 2010 Jul; 17(7):969-75. PubMed ID: 20236174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ex vivo MRI and histopathology detect novel iron-rich cortical inflammation in frontotemporal lobar degeneration with tau versus TDP-43 pathology.
    Tisdall MD; Ohm DT; Lobrovich R; Das SR; Mizsei G; Prabhakaran K; Ittyerah R; Lim S; McMillan CT; Wolk DA; Gee J; Trojanowski JQ; Lee EB; Detre JA; Yushkevich P; Grossman M; Irwin DJ
    Neuroimage Clin; 2022; 33():102913. PubMed ID: 34952351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multimarker synaptic protein cerebrospinal fluid panels reflect TDP-43 pathology and cognitive performance in a pathological cohort of frontotemporal lobar degeneration.
    Cervantes González A; Irwin DJ; Alcolea D; McMillan CT; Chen-Plotkin A; Wolk D; Sirisi S; Dols-Icardo O; Querol-Vilaseca M; Illán-Gala I; Santos-Santos MA; Fortea J; Lee EB; Trojanowski JQ; Grossman M; Lleó A; Belbin O
    Mol Neurodegener; 2022 Apr; 17(1):29. PubMed ID: 35395770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Event-based modeling of T1-weighted MRI is related to pathology in frontotemporal lobar degeneration due to tau and TDP.
    Olm CA; Burke SE; Peterson C; Lee EB; Trojanowski JQ; Massimo L; Irwin DJ; Grossman M; Gee JC
    Neuroimage Clin; 2023; 37():103285. PubMed ID: 36508888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presymptomatic and early pathological features of MAPT-associated frontotemporal lobar degeneration.
    Giannini LA; Mol MO; Rajicic A; van Buuren R; Sarkar L; Arezoumandan S; Ohm DT; Irwin DJ; Rozemuller AJ; ; van Swieten JC; Seelaar H
    Acta Neuropathol Commun; 2023 Aug; 11(1):126. PubMed ID: 37533060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of TDP-43 seeding activity in the olfactory mucosa from patients with frontotemporal dementia.
    Fontana E; Bongianni M; Benussi A; Bronzato E; Scialo C; Sacchetto L; Cagnin A; Castriciano S; Buratti E; Gardoni F; Italia M; Schreiber A; Ferracin C; Fiorini M; Newell KL; Cracco L; Garringer HJ; Cecchini MP; Polymenidou M; Padovani A; Monaco S; Legname G; Ghetti B; Borroni B; Zanusso G
    Alzheimers Dement; 2024 Feb; 20(2):1156-1165. PubMed ID: 37908186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TDP-43 subtypes are associated with distinct atrophy patterns in frontotemporal dementia.
    Rohrer JD; Geser F; Zhou J; Gennatas ED; Sidhu M; Trojanowski JQ; Dearmond SJ; Miller BL; Seeley WW
    Neurology; 2010 Dec; 75(24):2204-11. PubMed ID: 21172843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microglial burden, activation and dystrophy patterns in frontotemporal lobar degeneration.
    Woollacott IOC; Toomey CE; Strand C; Courtney R; Benson BC; Rohrer JD; Lashley T
    J Neuroinflammation; 2020 Aug; 17(1):234. PubMed ID: 32778130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneous ribonuclear protein A3 (hnRNP A3) is present in dipeptide repeat protein containing inclusions in Frontotemporal Lobar Degeneration and Motor Neurone disease associated with expansions in C9orf72 gene.
    Davidson YS; Flood L; Robinson AC; Nihei Y; Mori K; Rollinson S; Richardson A; Benson BC; Jones M; Snowden JS; Pickering-Brown S; Haass C; Lashley T; Mann DMA
    Acta Neuropathol Commun; 2017 Apr; 5(1):31. PubMed ID: 28431575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Truncated stathmin-2 is a marker of TDP-43 pathology in frontotemporal dementia.
    Prudencio M; Humphrey J; Pickles S; Brown AL; Hill SE; Kachergus JM; Shi J; Heckman MG; Spiegel MR; Cook C; Song Y; Yue M; Daughrity LM; Carlomagno Y; Jansen-West K; de Castro CF; DeTure M; Koga S; Wang YC; Sivakumar P; Bodo C; Candalija A; Talbot K; Selvaraj BT; Burr K; Chandran S; Newcombe J; Lashley T; Hubbard I; Catalano D; Kim D; Propp N; Fennessey S; ; Fagegaltier D; Phatnani H; Secrier M; Fisher EM; Oskarsson B; van Blitterswijk M; Rademakers R; Graff-Radford NR; Boeve BF; Knopman DS; Petersen RC; Josephs KA; Thompson EA; Raj T; Ward M; Dickson DW; Gendron TF; Fratta P; Petrucelli L
    J Clin Invest; 2020 Nov; 130(11):6080-6092. PubMed ID: 32790644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tau Rather than TDP-43 Proteins are Potential Cerebrospinal Fluid Biomarkers for Frontotemporal Lobar Degeneration Subtypes: A Pilot Study.
    Kuiperij HB; Versleijen AA; Beenes M; Verwey NA; Benussi L; Paterlini A; Binetti G; Teunissen CE; Raaphorst J; Schelhaas HJ; Küsters B; Pijnenburg YA; Ghidoni R; Verbeek MM
    J Alzheimers Dis; 2017; 55(2):585-595. PubMed ID: 27662293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.